Ming-Hui Duan (Minghui Duan)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Chronic Kidney Disease

Top Venues

Turkish journal of haematology : official journal of Turkish Society of Haematology

American journal of hematology

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Han Gao, Ming-Hui Duan, Jian Li, Lu Zhang
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Yu-Han Gao, Ming-Hui Duan, Jian Li, Lu Zhang
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Yan-Ting Liu, Yu-Han Gao, Hao Zhao, Miao-Yan Zhang, Ming-Hui Duan, Jian Li, Lu Zhang
Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study. Annals of hematology (2024)
Yu-Han Gao, Ming-Hui Duan, Jian Li, Lu Zhang
Successful treatment of relapsed idiopathic multicentric Castleman disease-idiopathic plasmacytic lymphadenopathy with orelabrutinib monotherapy: A case report. British journal of haematology (2024)
Yu-Han Gao, Ming-Hui Duan, Jian Li, Lu Zhang
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Yi Zhang, Hu Zhou, Ming-Hui Duan, Sujun Gao, Guang-Sheng He, Hongmei Jing, Junmin Li, Liangming Ma, Huan-Ling Zhu, Chunkang Chang, Xin Du, Mei Hong, Xin Li, Qingchi Liu, Wei Wang, Na Xu, Haiping Yang, Binhua Lu, Hewen Yin, Liqing Wu, Shanshan Suo, Qingwei Zhao, Zhijian Xiao, Jie Jin
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study. American journal of hematology (2023)
Ji-Nuo Wang, Ting Liu, Ai-Lin Zhao, Bo-Ju Pan, Jian Sun, Jian Li, Dao-Bin Zhou, Xin-Xin Cao, Ming-Hui Duan
Correction: Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis. Leukemia (2023)
Hong-Xiao Han, Long Chang, Min Lang, He Lin, Jian Li, Ming-Hui Duan, Dao-Bin Zhou, Xin-Xin Cao
Clinical characteristics, genomic profiling and outcomes of single system multifocal Langerhans cell histiocytosis in adults with bone involvement. Blood cancer journal 13 (1) (2023)
Hao Zhao, Miao-Yan Zhang, Kai-Ni Shen, Jun Feng, Xin-Xin Cao, Ming-Hui Duan, Dao-Bin Zhou, Lu Zhang, Jian Li
A phase 2 prospective study of bortezomib, cyclophosphamide, and dexamethasone in newly-diagnosed iMCD patients. Blood (2023)
Ai-Lin Zhao, Hao Cai, Jia Chen, Ming-Hui Duan, Dao-Bin Zhou, Jian Li, Xin-Xin Cao
The potential of cell-free DNA to reveal the molecular profiles of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Leukemia 36 (5) (2022)
Ji-Nuo Wang, Ting Liu, Ai-Lin Zhao, Bo-Ju Pan, Jian Sun, Jian Li, Dao-Bin Zhou, Xin-Xin Cao, Ming-Hui Duan
Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis. Leukemia 36 (6) (2022)
Jia Chen, Ai-Lin Zhao, Ming-Hui Duan, Hao Cai, Xue-Min Gao, Ting Liu, Jian Sun, Zhi-Yong Liang, Dao-Bin Zhou, Xin-Xin Cao, Jian Li
Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis. Leukemia (2021)
Xin-Xin Cao, Ming-Hui Duan, Ai-Lin Zhao, Hao Cai, Jia Chen, Xue-Min Gao, Ting Liu, Hua-Cong Cai, Lu Zhang, Jian Sun, Zhi-Yong Liang, Dao-Bin Zhou, Jian Li
Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis. American journal of hematology (2021)